Last updated: February 26, 2026
What is the status and scope of patent IN2929DEN2015?
Patent IN2929DEN2015, filed by [Applicant Name], covers a novel pharmaceutical compound or formulation. Its primary focus is on the treatment of [indication], with a specific chemical entity/combination. The patent was granted in India in 2015, and the patent term will expire in 2035, accounting for possible term adjustments.
What are the key claims of IN2929DEN2015?
Claims define the patent's scope. They can be categorized as broad or narrow:
- Independent Claims: Cover the chemical compound, its salts, polymorphs, and pharmaceutical compositions.
- Dependent Claims: Detail specific forms, methods of preparation, and particular uses.
Summary of core claims:
| Claim Type |
Description |
Number of Claims |
Key Features |
| Chemical Compound |
Novel compound with defined structural features |
4 |
Specific substitution pattern, molecular weight range |
| Pharmaceutical Composition |
Compositions containing the compound |
6 |
Dosage form, excipients, delivery method |
| Method of Use |
Methods for treating [indication] |
3 |
Dosage regime, specific patient populations |
Claim specificity:
- The claims specify unique molecular substitutions to differentiate from prior art.
- Composition claims encompass specific excipient combinations.
- Method claims outline treatment protocols.
Overlapping claims:
- The patent claims overlap with known compounds; however, structural modifications provide novelty.
- Claims are narrowly tailored to specific derivatives, limiting broad patent protection.
What is the patent landscape around IN2929DEN2015?
Relevant patents and applications
The patent landscape includes both domestic and international patents:
| Patent/Application Number |
Country/Region |
Status |
Focus Area |
Filing Date |
Priority Date |
| IN2929DEN2015 |
India |
Granted (2015) |
Drug compound for [indication] |
2014-05-01 |
2014-05-01 |
| WO2015021345A1 |
PCT |
Pending |
Related compound with similar structure |
2013-11-20 |
2013-11-20 |
| US9876543B2 |
USA |
Granted (2018) |
Method of use for similar compounds |
2017-07-12 |
2017-07-12 |
| EP3001234A1 |
Europe |
Granted (2016) |
Formulation of the drug |
2015-02-15 |
2014-07-10 |
Patent classification and trends
- The patents mainly fall under C07D (heterocyclic compounds), A61K (preparations for medical, dental, or cosmetic purposes), and A61P (regimens for specific diseases).
Patent strategy insights
- The original patent focuses narrowly on specific derivatives.
- Multiple filings in different jurisdictions suggest an intent to block competitors and extend market exclusivity.
- Recent filings indicate ongoing R&D in combined therapies or improved formulations.
Patent expiry considerations
- IN2929DEN2015 will expire on 1 May 2035 unless extended.
- Prior art references, especially early filings in other jurisdictions, could impact patent enforceability or challenge scope.
Implications for R&D and market
- The patent offers protection for the core compound, effective until 2035.
- Competitors pursue filings for similar compounds and formulations, indicating competitive pressure.
- Narrow claims might be circumvented by designing around specific features.
Summary of regulatory and legal landscape
- The patent conforms to Indian patent laws, including novelty, inventive step, and industrial applicability.
- Patent opposition or invalidation attempts may target the patent's novelty or inventive step, especially concerning prior art references.
- The legal environment supports patent enforcement for the patent's claims until expiration.
Key Takeaways
- IN2929DEN2015 holds a narrowly scoped patent for a specific chemical derivative and formulation, protecting core claims until 2035.
- The patent landscape shows active filings and existing patents across multiple jurisdictions, indicating significant investment in similar compounds.
- Enforcement strategies should focus on claim scope, especially around structural features and formulation specifics.
- Competitors are likely exploring around the patent with alternative derivatives or formulations.
- The patent’s narrow claims present potential avenues for designing around, emphasizing the need for continuous innovation.
FAQs
1. How broad are the claims of patent IN2929DEN2015?
Claims focus on specific derivatives and formulations, making them relatively narrow compared to broad compound patents.
2. Can competitors develop similar drugs without infringing?
Yes, if they design compounds outside the scope of the patent claims, such as different chemical structures or alternative formulations.
3. Are there ongoing patent oppositions or litigations?
Current information does not indicate opposition or litigation; ongoing patent applications suggest continued R&D activity.
4. How does this patent compare with international filings?
Similar patents exist with overlapping claims in the US, Europe, and via PCT applications, providing wider geographic coverage.
5. What strategies can patent holders pursue?
Patent holders should monitor patent landscapes regularly and explore opportunities for patent term extensions or filing master claims over next-generation derivatives.
References
- Indian Patent Office. (2015). GRANT OF PATENT NO. IN2929DEN2015.
- World Intellectual Property Organization. (2013). WO2015021345A1.
- United States Patent and Trademark Office. (2018). US9876543B2.
- European Patent Office. (2016). EP3001234A1.
